A federal court in Massachusetts has granted Pfizer and BioNTech’s motion to put on hold Moderna’s lawsuit over alleged ...
Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) shares are trading in the red on Friday, on track for the eighth ...
Think it's time for a booster? Moderna says its newest COVID vaccine is showing signs of a stronger immune response against the virus than the current shot being offered and a longer shelf-life.
As with any investment your capital is at risk. Moderna gained global fame for its Covid-19 vaccine, which the biotech company hopes will be the first of many transformative applications of its ...
In a press release issued in Denmark by the Danish Medicines Agency, media have been informed that a side effect of taking Moderna's COVID vaccine, also known as Spikevax, may result in chronic hives.
It also had plans to start filling doses of its COVID vaccine in the continent as early as 2023. However, Moderna has not received ... Financecategory JPMorgan CEO Dimon sells about $33 mln ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
It comes after Pfizer and Moderna, the two key suppliers of Covid vaccines ... with the high price of Boots’ service reflective of the higher cost set by vaccine manufacturers.
CAMBRIDGE, MA / ACCESSWIRE / March 26, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints ...
Vaccine uses patient's own tumor and immune system to fight recurrence of skin cancer. When you think of Moderna mRNA vaccines, you probably think of COVID-19 ... carry a heavy price tag ...
Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for Covid-19 vaccines. Moderna said on Thursday it ...